&Partners’s SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.95M Buy
23,566
+5,323
+29% +$441K 0.02% 678
2025
Q1
$1.54M Sell
18,243
-104
-0.6% -$8.78K 0.02% 641
2024
Q4
$1.69M Buy
18,347
+11,678
+175% +$1.08M 0.02% 567
2024
Q3
$659K Buy
6,669
+730
+12% +$72.1K 0.01% 739
2024
Q2
$551K Buy
5,939
+460
+8% +$42.6K 0.02% 506
2024
Q1
$520K Hold
5,479
0.07% 258
2023
Q4
$489K Buy
5,479
+6
+0.1% +$536 0.12% 158
2023
Q3
$400K Sell
5,473
-1,130
-17% -$82.5K 0.19% 99
2023
Q2
$549K Hold
6,603
0.25% 78
2023
Q1
$503K Hold
6,603
0.24% 85
2022
Q4
$548K Sell
6,603
-100
-1% -$8.3K 0.27% 75
2022
Q3
$532K Sell
6,703
-145
-2% -$11.5K 0.31% 75
2022
Q2
$509K Buy
6,848
+473
+7% +$35.2K 0.29% 79
2022
Q1
$573K Sell
6,375
-50
-0.8% -$4.49K 0.32% 74
2021
Q4
$719K Buy
6,425
+500
+8% +$56K 0.43% 56
2021
Q3
$745K Sell
5,925
-110
-2% -$13.8K 0.47% 53
2021
Q2
$817K Buy
6,035
+220
+4% +$29.8K 0.53% 42
2021
Q1
$789K Hold
5,815
0.57% 44
2020
Q4
$819K Sell
5,815
-225
-4% -$31.7K 0.69% 41
2020
Q3
$673K Hold
6,040
0.68% 43
2020
Q2
$676K Sell
6,040
-200
-3% -$22.4K 0.82% 35
2020
Q1
$483K Hold
6,240
0.75% 40
2019
Q4
$593K Hold
6,240
0.71% 47
2019
Q3
$476K Sell
6,240
-375
-6% -$28.6K 0.62% 59
2019
Q2
$580K Hold
6,615
0.8% 41
2019
Q1
$599K Buy
6,615
+60
+0.9% +$5.43K 0.86% 35
2018
Q4
$461K Buy
+6,555
New +$461K 0.77% 37